Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Vorbipiprant |
| Trade Name | |
| Synonyms | CR 6086|CR-6086|CR6086 |
| Drug Descriptions |
Vorbipiprant (CR6086) is an antagonist of the prostaglandin E2 receptor 4 (EP4) with potential immunomodulatory activity, and may enhance inhibition of tumor growth (PMID: 29490676, Cancer Res 2020;80(16 Suppl):Abstract nr 2208). |
| DrugClasses | |
| CAS Registry Number | 1417742-86-9 |
| NCIT ID | C186659 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Balstilimab + Vorbipiprant | Balstilimab Vorbipiprant | 0 | 1 |
| Nivolumab + Vorbipiprant | Nivolumab Vorbipiprant | 0 | 1 |
| Vorbipiprant | Vorbipiprant | 0 | 1 |